Six drug makers in race for top post for anti-obesity market.

Six pharmaceutical firms for producing sibutramine are engaged in cutthroat competition to take the top place in Korea's anti-obesity market with more heated promotional activities following expiration of Abbott's Reductil, according to industry sources.

With Abbott leading the van in the heated race, other five Korean drugmakers, including Hanmi Pharm (Slimmer), Daewoong (NVU), CJ (Diatrami...